Non-Invasive and Rapid Diagnosis of Type 2 Diabetes Using Urinary Acetone: a Prospective Multi - Center Study
Wei Xu,Xue Zou,Houwen Ding,Jin Zhang,Wenting Liu,Tingting Gong,Min Yang,Qiang Zhou,Qin Wang,Xiubing Hang,Zhou Liu,Zhengchao Nie,Ling Zheng,Hui Li,Wenyan Xiao,Heping Zuo,Dianlong Ge,Qiangling Zhang,Chaoqun Huang,Chengyin Shen,Yannan Chu
DOI: https://doi.org/10.2139/ssrn.4113125
2022-01-01
SSRN Electronic Journal
Abstract:Background: Urinary acetone is produced from fat metabolism in human body, which can be accelerated in diabetic patients because of insufficient utilization and storage of glucose. Therefore, it has the potential to be used for diagnosis of type 2 diabetes (T2D).Methods: We recruited 180 T2D patients and 180 healthy volunteers from three hospitals for a multi-center study. Urine samples were collected in the morning when donators were fasting and stored in glass bottles. Acetone in the headspace of these bottles was qualitatively and quantitatively detected by a proton transfer reaction mass spectrometry (PTR-MS) instrument in eight hours. The detection time was less than one minute. Diagnostic model was established using urinary acetone data from one hospital and validated in another two hospitals. Findings: Using a threshold of 644.1 ppb, a diagnostic model was established using urinary acetone with an accuracy of 81.3% (sensitivity: 73.3%, specificity: 89.3%) in hospital Ⅰ. In the verification studies, the accuracies were 92.5% (sensitivity: 88.7%, specificity: 96.2%) in hospital Ⅱ and 83.7% (sensitivity: 76.9%, specificity: 90.4%) in hospital Ⅲ, respectively. The sensitivity for 35 newly diagnosed patients was 85.7%. The accuracy is comparable to that of clinically used diagnosis methods, fasting plasma glucose (FPG), oral glucose tolerance test (OGTT), and glycosylated hemoglobin (HbA1c) test. In addition, the urinary acetone had good linear relation to HbA1c but poor linear relation to FPG, two main T2D biomarkers in clinical tests.Interpretation: The newly developed technology is completely non-invasive and much more rapid than clinical FPG, OGTT, and HbA1c tests. It has the potential to become a novel T2D diagnosis method. But its applicability in different human races still need more validations.Funding: This research was funded by National Natural Science Foundation of China (22076190), Youth Innovation Promotion Association, CAS (2019432), Joint Fund between the Second Affiliated Hospital of Anhui Medical University and the Center of Medical Physics and Technology of Hefei Institute of Physical Sciences of Chinese Academy of Sciences (LHJJ2020006), and President Foundation of Hefei Institute of Physical Sciences of Chinese Academy of Sciences (YZJJ2022QN45, YZJJZX202009).Declaration of Interest: The authors declare that they have no conflict of interest.Ethical Approval: This study was approved by the ethics committee of the Second Hospital of Anhui Medical University.